Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?

• 主要な著者: Nabil Ismaili (著者), Sanaa Elmajjaoui (著者), Youssef Bensouda (著者), Rhizlane Belbaraka (著者), Halima Abahssain (著者), Wafa Allam (著者), Zouhour Fadoukhair (著者), Mohamed Mesmoudi (著者), Rachid Tanz (著者), Tarik Mahfoud (著者), Abdelhamid Elomrani (著者), Mouna Khouchani (著者), Yassir Sbitti (著者), Noureddine Benjaafar (著者), Hassan Errihani (著者), Ali Tahri (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2011-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Bladder cancer is the fourth most common cancer for men and the eighth most common cancer for women. Transitional cell carcinoma is the most predominant histological type. Bladder cancer is highly chemosensitive. In metastatic setting the treatment is based on cisplatin chemotherapy regimens type MV...